Literature DB >> 10364380

The subgenus-specific C-terminal region of protein IX is located on the surface of the adenovirus capsid.

A Akalu1, H Liebermann, U Bauer, H Granzow, W Seidel.   

Abstract

We have investigated the antigenicity of the C- and N-terminal halves of pIX of human adenovirus types 2 and 3 (Ad2 and Ad3) as well as their orientations in virions. We found that only the C-terminal halves of Ad2 pIX and Ad3 pIX reacted in a subgenus-specific manner by enzyme-linked immunosorbent assay and immunoblot analysis. Based on immunoelectron microscopy experiments, pIX in viral capsids appears to be positioned such that the C-terminal part of pIX constitutes the surface domain whereas the N terminus of the protein makes up the internal domain in icosahedral Ad capsids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364380      PMCID: PMC112689     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

Review 2.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

3.  Establishing homologies in protein sequences.

Authors:  M O Dayhoff; W C Barker; L T Hunt
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  The 2.2 kb E1b mRNA of human Ad12 and Ad5 codes for two tumor antigens starting at different AUG triplets.

Authors:  J L Bos; L J Polder; R Bernards; P I Schrier; P J van den Elsen; A J van der Eb; H van Ormondt
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

5.  Immunoprecipitation with two-dimensional pools as a hybridoma screening technique: production and characterization of monoclonal antibodies against adenovirus 2 proteins.

Authors:  C L Cepko; P S Changelian; P A Sharp
Journal:  Virology       Date:  1981-04-30       Impact factor: 3.616

6.  The nucleotide sequence of the polypeptide IX gene of human adenovirus type 3.

Authors:  J A Engler
Journal:  Gene       Date:  1981-05       Impact factor: 3.688

7.  The nucleotide sequence of adenovirus type 5 early region E1: the region between map positions 8.0 (HindIII site) and 11.8 (SmaI site).

Authors:  J Maat; C P van Beveren; H van Ormondt
Journal:  Gene       Date:  1980-06       Impact factor: 3.688

8.  The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA.

Authors:  P Aleström; G Akusjärvi; M Perricaudet; M B Mathews; D F Klessig; U Pettersson
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

9.  Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX.

Authors:  W W Colby; T Shenk
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

10.  The gene for polypeptide IX of human adenovirus type 7.

Authors:  R Dijkema; J Maat; B M Dekker; H van Ormondt; H W Boyer
Journal:  Gene       Date:  1981-05       Impact factor: 3.688

View more
  14 in total

1.  Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization.

Authors:  M Rosa-Calatrava; L Grave; F Puvion-Dutilleul; B Chatton; C Kedinger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostability.

Authors:  Jort Vellinga; Diana J M van den Wollenberg; Stephanie van der Heijdt; Martijn J W E Rabelink; Rob C Hoeben
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 3.  Transductional targeting of adenovirus vectors for gene therapy.

Authors:  J N Glasgow; M Everts; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-27       Impact factor: 5.987

Review 4.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

5.  Structures and organization of adenovirus cement proteins provide insights into the role of capsid maturation in virus entry and infection.

Authors:  Vijay S Reddy; Glen R Nemerow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

6.  Detection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay.

Authors:  Ulrike Bauer; Gisela Flunker; Kornelia Bruss; Knut Kallwellis; Herbert Liebermann; Tanja Luettich; Manfred Motz; Werner Seidel
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.

Authors:  Samuel K Campos; M Brandon Parrott; Michael A Barry
Journal:  Mol Ther       Date:  2004-06       Impact factor: 11.454

8.  Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.

Authors:  Igor P Dmitriev; Elena A Kashentseva; David T Curiel
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Derivation of a triple mosaic adenovirus for cancer gene therapy.

Authors:  Yizhe Tang; Hongju Wu; Hideyo Ugai; Qiana L Matthews; David T Curiel
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

10.  Unique sequence features of the Human adenovirus 31 complete genomic sequence are conserved in clinical isolates.

Authors:  Soeren Hofmayer; Ijad Madisch; Sebastian Darr; Fabienne Rehren; Albert Heim
Journal:  BMC Genomics       Date:  2009-11-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.